NASDAQ
Gene Biotherapeutics, Inc. (CRXM) has a current ratio of 0.08x as of Monday, May 25, 2026. This represents a 29.50% increase compared to its 12-month average of 0.06x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.